Columbia Asset Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $212K | Sell |
|
|||||
|
2025
Q1 | $248K | Sell |
|
|||||
|
2024
Q4 | $233K | Sell |
|
|||||
|
2024
Q3 | $373K | Buy |
|
|||||
|
2024
Q2 | $351K | Buy |
|
|||||
|
2024
Q1 | $309K | Hold |
|
|||||
|
2023
Q4 | $309K | Sell |
|
|||||
|
2023
Q3 | $361K | Buy |
|
|||||
|
2023
Q2 | $344K | Buy |
|
|||||
|
2023
Q1 | $331K | Buy |
|
|||||
|
2022
Q4 | $270K | Buy |
|
|||||
|
2022
Q3 | $157K | Sell |
|
|||||
|
2022
Q2 | $334K | Buy |
|
|||||
|
2021
Q4 | $430K | Sell |
|
|||||
|
2021
Q3 | $405K | Sell |
|
|||||
|
2021
Q2 | $434K | Sell |
|
|||||
|
2021
Q1 | $457K | Sell |
|
|||||
|
2020
Q4 | $597K | Buy |
|
|||||
|
2020
Q3 | $589K | Sell |
|
|||||
|
2020
Q2 | $668K | Buy |
|
|||||
|
2020
Q1 | $542K | Sell |
|
|||||
|
2019
Q4 | $7.17K | Hold |
|
|||||
|
2019
Q3 | $652K | Buy |
|
|||||
|
2019
Q2 | $611K | Sell |
|
|||||
|
2019
Q1 | $736K | Buy |
|
|||||
|
2018
Q4 | $582K | Buy |
|
|||||
|
2018
Q3 | $608K | Sell |
|
|||||
|
2018
Q2 | $660K | Hold |
|
|||||
|
2018
Q1 | $640K | Buy |
|
|||||
|
2017
Q4 | $554K | Sell |
|
|||||
|
2017
Q3 | $892K | Buy |
|
|||||
|
2017
Q2 | $902K | Buy |
|
|||||
|
2017
Q1 | $709K | Buy |
|
|||||
|
2016
Q4 | $573K | Sell |
|
|||||
|
2016
Q3 | $691K | Buy |
|
|||||
|
2016
Q2 | $565K | Sell |
|
|||||
|
2016
Q1 | $572K | Sell |
|
|||||
|
2015
Q4 | $583K | Buy |
|
|||||
|
2015
Q3 | $498K | Sell |
|
|||||
|
2015
Q2 | $634K | Buy |
|
|||||
|
2015
Q1 | $700K | Buy |
|
|||||
|
2014
Q4 | $537K | Buy |
|
|||||
|
2014
Q3 | $461K | Sell |
|
|||||
|
2014
Q2 | $541K | Buy |
|
|||||
|
2014
Q1 | $499K | Buy |
|
|||||
|
2013
Q4 | $478K | Buy |
|